Eyenovia Inc.

1.13
0.04 (3.66%)
At close: Apr 24, 2025, 3:59 PM
1.15
1.77%
After-hours: Apr 24, 2025, 07:37 PM EDT
3.66%
Bid 1.02
Market Cap 3.2M
Revenue (ttm) 57.34K
Net Income (ttm) -49.82M
EPS (ttm) -59.81
PE Ratio (ttm) -0.02
Forward PE -0.08
Analyst Hold
Ask 1.15
Volume 47,078
Avg. Volume (20D) 275,833
Open 1.18
Previous Close 1.09
Day's Range 1.10 - 1.18
52-Week Range 0.85 - 124.80
Beta 1.20

About EYEN

Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the development of therapeutic indications for patients with progressive myopia and age-related near vision impair...

Industry Biotechnology
Sector Healthcare
IPO Date Jan 25, 2018
Employees 13
Stock Exchange NASDAQ
Ticker Symbol EYEN
Full Company Profile

Analyst Forecast

According to 4 analyst ratings, the average rating for EYEN stock is "Hold." The 12-month stock price forecast is $2, which is an increase of 76.99% from the latest price.

Stock Forecasts

Earnings Surprise

Eyenovia has released their quartely earnings on Apr 15, 2025:
  • Revenue of $28.09K misses estimates by $1.57M, with 985.09% YoY growth.
  • EPS of -17.41 misses estimates by -9.41, with -20.90% YoY decline.
  • Next Earnings Release

    Eyenovia Inc. is scheduled to release its earnings on May 2, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 month ago
    -13.77%
    Eyenovia shares are trading lower after the compan... Unlock content with Pro Subscription
    1 month ago
    +16.56%
    Eyenovia shares are trading higher after the company announced it regained Nasdaq complaince.